Search NLS News

The 2019 Nobel Prize in Physiology or Medicine was awarded to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for revealing the mechanism of one of life’s most essential adaptive processes.

Imagine this … A new pandemic hits the US. There’s a lack of knowledge about the virus that causes the illness, about the disease’s epidemiology, clinical symptoms, and treatment, and about the effective preventative measures that could be introduced in a modern, liberal society. In five small adjoining US states, the authorities decide to invest […]

A new report from industry organization SwedenBIO shows that Swedish pharmaceutical manufacturing and research remains strong and the country continues to be a prominent player in life sciences. The Swedish Drug Discovery and Development Pipeline report is produced every three years and is the only one of its kind. It maps the drug projects under […]

The partners in Pandemic Antiviral Discovery (PAD) initiative has announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans. These grants mark the majority of the first investments to come from the PAD initiative, a global philanthropic collaboration […]

Oncopeptides has been informed by the Swedish Economic Crime Authority that the CSO Jakob Lindberg has been arrested for a suspected violation of the Market Abuse Act (Sw. lag om straff för marknadsmissbruk på värdepappersmarknaden). The company does currently not have any additional information but will provide an update to the market when we have […]

Affibody and Chiesi Group have announced the execution of a collaboration and licensing agreement to develop and commercialize innovative treatments for respiratory diseases using Affibody’s technology. Under the terms of the agreement, the parties will collaborate closely to progress up to three programs based on Affibody molecules against undisclosed targets for respiratory diseases. Chiesi will […]

Novo Nordisk has announced plans to expand its research and development (R&D) presence in the greater Boston metro area, creating one of its largest R&D hubs outside of Denmark. This new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, Massachusetts, will be home to the majority of Novo Nordisk’s US-based […]

Immunovia has announced the appointment of Karl Stone as Chief Operating Officer effective 1 March, 2023. Immunovia has added a new Chief Operating Officer role to its executive team to align with strategic priorities and focus on the US commercialization of the IMMray PanCan-d test, it states. The Chief Operating Officer will be responsible for […]

The US Patent and Trademark Office (USPTO) and the Japanese Patent Office have informed Diamyd Medical that they will grant the patent for the company’s oral formulation of the GABA-based study drug Remygen. Remygen is currently in Phase 2 development through the ReGenerate-1 trial in individuals with long-term Type 1 Diabetes. Results are expected later […]

The company’s new Chief Medical Officer (CMO) is Pia Baumann. As member of the company’s management team her responsibilities include the continued clinical development of the candidate drug fostroxacitabine bralpamide (fostrox), states the company. “I am very pleased that Pia now has taken up the role as Chief Medical Officer. She is joining us at […]